# A Pilot-Study of Sirolimus for the Treatment of Systemic Sclerosis

> **NCT03365869** · PHASE2 · UNKNOWN · sponsor: **Peking University People's Hospital** · enrollment: 72 (estimated)

## Conditions studied

- Systemic Sclerosis

## Interventions

- **DRUG:** Sirolimus

## Key facts

- **NCT ID:** NCT03365869
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-01
- **Primary completion:** 2018-12-31
- **Final completion:** 2019-06-30
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2017-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03365869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03365869, "A Pilot-Study of Sirolimus for the Treatment of Systemic Sclerosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03365869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*